Kolmar Holdings
콜마홀딩스 · 024720
Financials Diversified Financials · KOSPI
Market cap US$213.2M (₩294.3B)
Overview
Kolmar Holdings is a holding company, a firm that owns stakes in other companies rather than making products itself, whose subsidiaries develop and manufacture health supplements, cosmetics, and pharmaceuticals.
It sits at the top of a group of operating companies, collecting trademark-licensing fees, management-service fees, dividends, and rental income from those subsidiaries. Listed on KOSPI, Korea's main stock exchange, its own revenue moves in step with the performance of its subsidiary businesses.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$461.8M
- FY2024US$490.3M
- FY2025US$456.6M
Operating profit
- FY2023US$12.2M
- FY2024US$27.6M
- FY2025US$34.6M
Net income
- FY2023US$4.4M
- FY2024US$24.2M
- FY2025US$8.1M
Key ratios (FY2025)
Why it matters
Under Korean law, Kolmar Holdings is formally designated as a holding company, meaning its primary legal purpose is to control other companies through share ownership rather than to operate directly.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?